Ray Dalio's VCYT Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 91,590 shares of Veracyte, Inc. (VCYT) worth $2.95 M, representing 0.01% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Ray Dalio has initiated a new position in VCYT, representing a fresh investment thesis on this company. Largest addition occurred in Q1 2026, adding 63,196 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Veracyte (VCYT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Veracyte (VCYT) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +63,196 | Add 222.57% | 91,590 | $32.21 |
| Q4 2025 | +28,394 | New Buy | 28,394 | $42.10 |
Ray Dalio's Veracyte Investment FAQs
Ray Dalio first purchased Veracyte, Inc. (VCYT) in Q4 2025, acquiring 28,394 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Veracyte, Inc. (VCYT) for 2 quarters since Q4 2025.
Ray Dalio's largest addition to Veracyte, Inc. (VCYT) was in Q1 2026, adding 91,590 shares worth $2.95 M.
According to the latest 13F filing for Q1 2026, Ray Dalio's firm, Bridgewater Associates, Lp, owns 91,590 shares of Veracyte, Inc. (VCYT), valued at approximately $2.95 M.
As of the Q1 2026 filing, Veracyte, Inc. (VCYT) represents approximately 0.01% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Veracyte, Inc. (VCYT) was 91,590 shares, as reported at the end of Q1 2026.